Publication | Closed Access

Butyl 2-(4-[1.1′-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain

Molecular PharmacologyMedicinal ChemistryPain DisordersHealth SciencesPain MedicineMedicineNeuropathic PainIon ChannelsPharmacological AgentMolecular PainPain ManagementPharmacotherapyPain MechanismPharmacologyDrug DiscoveryPain Research